GLP-1 Vitamins & Nutrients: Personalized Supplementation Guide

Last reviewed: June 2, 2026

Last updated: June 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 medications like semaglutide and tirzepatide can reduce appetite and alter eating patterns, potentially affecting micronutrient intake and absorption. Studies show that patients on GLP-1 therapy may experience lower intake of B vitamins, minerals, and protein, necessitating thoughtful supplementation strategies tailored to individual needs.

Understanding your micronutrient status before and during GLP-1 treatment is part of precision wellness—moving beyond one-size-fits-all supplementation to biomarker-informed, personalized approaches. PlexusDx helps patients and providers identify genetic predispositions that may influence nutrient metabolism and medication response, supporting more targeted clinical conversations.

How GLP-1 Medications Affect Nutrient Status

GLP-1 agonists slow gastric emptying and reduce appetite, which can lower overall food intake and dietary diversity. This reduced caloric and nutrient density creates risk for deficiencies in B12, folate, iron, calcium, and protein—nutrients critical for metabolic health, energy, and bone density during weight loss.

Additionally, altered gut pH and reduced gastric acid from decreased meal frequency may impair absorption of certain minerals. Research suggests patients on GLP-1 therapy experience 15–25% lower micronutrient intake compared to baseline, making proactive monitoring and supplementation a clinical priority.

Critical Micronutrients to Monitor and Supplement

Evidence-based supplementation should focus on nutrients most at risk during GLP-1 treatment. The following table outlines key micronutrients, why they matter, and evidence-supported intake targets for patients on GLP-1 therapy.

Micronutrient	Clinical Role	At-Risk Population	Typical Recommendation
Vitamin B12	Energy metabolism, nerve function, red blood cell formation	Reduced intake, decreased intrinsic factor with age	1,000–2,000 mcg/week IM or 1,000 mcg/day sublingual
Folate	DNA synthesis, cell division, pregnancy support	Limited vegetable intake on GLP-1	400–800 mcg/day or methylfolate 500 mcg/day
Iron	Oxygen transport, energy production	Reduced meat/plant intake, female reproductive age	18–50 mg/day (or 8 mg males); check ferritin baseline
Calcium + Vitamin D	Bone health, muscle function, metabolic health	Rapid weight loss accelerates bone turnover	1,000–1,200 mg Ca + 1,000–2,000 IU Vitamin D/day
Protein	Muscle preservation, satiety, immune function	Reduced overall food intake	1.2–1.6 g/kg body weight daily or 90–120g/day minimum

Genetic Predispositions and Nutrient Metabolism Variability

Not all patients metabolize nutrients at the same rate. Genetic variants in folate metabolism, B12 absorption, and iron homeostasis can influence how your body processes and stores micronutrients. Some individuals carry variants that reduce methylation efficiency or impair absorption capacity, making supplementation timing and dose more critical.

PlexusDx's Precision Peptide Genetic Test reveals predispositions in peptide metabolism pathways—including variants affecting nutrient-sensing hormones and metabolic efficiency. While this test focuses on peptide pathway predispositions rather than pharmacogenomics, understanding your genetic context may help provide clinical insight into personalized micronutrient needs and metabolic resilience during treatment.

Timing, Interactions, and Safety Considerations

Supplement timing matters. B12, iron, and calcium have distinct absorption windows and interactions; taking them together or with GLP-1 medications may reduce bioavailability. A qualified healthcare provider should recommend staggered dosing—typically B12 and iron in the morning on an empty stomach, calcium and Vitamin D with a small meal, separate from GLP-1 injection.

Safety is paramount. Certain supplements (e.g., high-dose iron, magnesium) can cause GI upset when GLP-1 therapy is slowing motility. Baseline lab work—including complete metabolic panel, B12, folate, iron studies, and calcium/vitamin D—should establish individual needs before supplementation begins. Regular monitoring every 3–6 months helps adjust doses and detect deficiencies early.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context for your personalized micronutrient strategy by revealing predispositions in genes affecting metabolic efficiency and nutrient sensing. Key variants (GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, MC4R rs17782313) influence how your body processes energy and responds to appetite signals—information that can support a more informed supplementation conversation with your provider.

The Precision Peptide Genetic Test identifies predispositions in peptide pathways, not exact medication response or nutrient absorption capacity. However, understanding your genetic context—whether you carry variants associated with metabolic efficiency or appetite dysregulation—can help your healthcare team anticipate which micronutrient needs may be most pressing during your GLP-1 treatment journey.

When combined with baseline biomarkers (B12, folate, iron, calcium status) and genetic insights, this information supports a collaborative conversation between you and your provider about personalized supplementation timing, dosing, and monitoring intervals. It shifts supplementation from generic recommendations to precision wellness tailored to your unique physiology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral is $349/mo month-to-month, or from $279/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which nutrients does this article flag as most at risk during GLP-1 treatment?

It names vitamin B12, folate, iron, calcium paired with vitamin D, and protein. The reasoning it gives is that slowed gastric emptying and reduced appetite lower both total intake and dietary diversity, which puts nutrients tied to energy metabolism, red blood cell formation, bone density, and muscle preservation at risk during a period of active weight loss.

Why does the post single out protein during weight loss on a GLP-1?

Because of muscle preservation. The table lists protein's roles as muscle preservation, satiety, and immune function, and identifies reduced overall food intake as the at-risk mechanism. It gives a body-weight-scaled daily target, but how much protein is right for a specific person depends on kidney function, activity, and clinical goals, so that number belongs in a conversation with a provider or dietitian.

What baseline lab work does the article say should come before supplementation?

It says a complete metabolic panel plus B12, folate, iron studies, and calcium and vitamin D should establish individual needs before any supplementation begins, with repeat monitoring every three to six months to adjust and catch deficiencies early. It also warns that high-dose iron and magnesium can worsen gastrointestinal upset when a GLP-1 is already slowing motility.

Does the article's supplement table amount to a plan a reader can follow on their own?

No, and it should not be used that way. The table prints specific daily and weekly amounts, including an injectable B12 route, without accounting for existing deficiencies, kidney function, interacting medications, or pregnancy. Supplement amounts at those levels are a clinical decision. The useful part of the table is the list of nutrients worth testing; the numbers belong to whoever is ordering the labs.

Where does the article's '15-25% lower micronutrient intake' figure come from?

Nowhere the reader can check. The post states that research suggests patients on GLP-1 therapy take in 15-25% less than baseline, but names no study, population, or measurement method. The mechanism it describes is plausible, since eating less overall generally means taking in fewer micronutrients, but the specific range is unverified and should not be treated as an established finding.

Related Reading

• Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications
• Glp 1 Providers That Accept Wellness Stipend Plexusdx
• Glp 1 Medications
• Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.